Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
42.21
+1.10 (2.68%)
Nov 21, 2024, 12:04 PM EST - Market open
Twist Bioscience Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 52.25, with a low estimate of 35 and a high estimate of 65. The average target predicts an increase of 23.79% from the current stock price of 42.21.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TWST stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 9 | 9 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $55 → $52 | Buy | Maintains | $55 → $52 | +23.19% | Nov 19, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $50 → $54 | Buy | Maintains | $50 → $54 | +27.93% | Nov 19, 2024 |
| Baird | Baird | Buy Maintains $46 → $48 | Buy | Maintains | $46 → $48 | +13.72% | Nov 19, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $52 → $56 | Buy | Maintains | $52 → $56 | +32.67% | Oct 1, 2024 |
| Barclays | Barclays | Buy Maintains $60 → $55 | Buy | Maintains | $60 → $55 | +30.30% | Aug 5, 2024 |
Financial Forecast
Revenue This Year
316.98M
from 245.11M
Increased by 29.32%
Revenue Next Year
378.84M
from 316.98M
Increased by 19.52%
EPS This Year
-3.62
from -3.60
EPS Next Year
-2.48
from -3.62
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 327.4M | 407.8M | 489.5M | ||
| Avg | 317.0M | 378.8M | 455.2M | ||
| Low | 303.8M | 345.0M | 414.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 33.6% | 28.7% | 29.2% | ||
| Avg | 29.3% | 19.5% | 20.2% | ||
| Low | 23.9% | 8.8% | 9.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.05 | -2.19 | -1.44 | ||
| Avg | -3.62 | -2.48 | -1.80 | ||
| Low | -3.68 | -2.70 | -2.06 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.